查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1322030

全球心臟再同步治療 (CRT) 市場（2023-2030）：按類型、應用（心室內異步、心室間異步）和最終用戶劃分的規模、份額、增長分析和預測

Global Cardiac Resynchronization Therapy Market Size, Share, Growth Analysis, By Type, By Application(Intraventricular desynchrony, Interventricular desynchrony), By End User - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球心臟再同步治療 (CRT) 市場規模預計將從 2021 年的 40.6 億美元增長到 2022 年的 42.6 億美元，預測期內復合年增長率為 4.8%，到 2030 年預計還將增長2019年達到62.3億美元。

CRT 是一種治療心力衰竭患者的方法。 由於全球心血管疾病患病率不斷上升，全球 CRT 市場正在顯著增長。 CRT 設備有助於恢復同步心臟收縮並改善心臟功能和生活質量。 技術進步、意識增強和老年人口增加等因素正在推動市場擴張。 此外，有利的報銷政策和持續的研發活動預計也將在未來幾年進一步推動市場增長。

儘管預防和治療取得了進展，但心血管疾病導致的死亡中約有 50% 是由於心源性猝死。 這仍然是一個重要的死亡原因。 心髒病及其危險因素的患病率不斷增加，增加了對 CRT 設備的需求。

本報告調查了全球心臟再同步治療 (CRT) 市場，並提供了市場概況、影響市場的各種因素分析、技術和創新趨勢、監管環境以及市場規模趨勢和預測。分類和地區、競爭狀況、主要公司簡介等。

目錄

  • 執行摘要
  • 調查方法
  • 母公司市場分析
  • 市場概覽
  • 市場規模
  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 作業
  • 主要市場洞察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 知識產權分析
    • 貿易分析
    • 啟動分析
    • 原材料分析
    • 創新矩陣
    • 管道產品分析
    • 宏觀經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態和前景
    • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 作業
  • 監管狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
  • 按類型劃分的全球心臟再同步治療 (CRT) 市場
    • 市場概覽
    • CRT 除顫器 (CRT-D)
    • CRT起搏器
  • 全球心臟再同步治療 (CRT) 市場：按應用分類
    • 市場概覽
    • 室內異步
    • 心室 (VV) 異步
    • 房室 (AV) 異步
  • 最終用戶的全球心臟再同步治療 (CRT) 市場
    • 市場概覽
    • 醫院
    • 心臟護理中心
    • 門診手術中心
  • 按地區劃分的全球心臟再同步治療 (CRT) 市場
    • 市場概覽
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 競爭狀況
  • 排名前 5 名的公司比較
  • 主要公司的市場地位
  • 各大公司的招聘策略
  • 關鍵成功策略
  • 近期市場活動
  • 主要公司的市場份額
  • 主要公司簡介
    • Medtronic
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • LivaNova PLC
    • St. Jude Medical, Inc.
    • EBR Systems, Inc.
    • Cardiac Dimensions, Inc.
    • Sorin Group
    • Cook Medical, Inc.
    • Osprey Medical, Inc.
    • BioVentrix, Inc.
    • MicroPort Scientific Corporation
    • Endologix, Inc.
    • InspireMD, Inc.
    • Integer Holdings Corporation
    • Inari Medical, Inc.
    • Syncardia Systems, Inc.
    • AngioDynamics, Inc.
    • Cardiva Medical, Inc.
簡介目錄
Product Code: SQMIG35D2074

Global Cardiac Resynchronization Therapy Market size was valued at USD 4.06 billion in 2021 and is poised to grow from USD 4.26 billion in 2022 to USD 6.23 billion by 2030, growing at a CAGR of 4.8% in the forecast period (2023-2030).

Cardiac resynchronization therapy (CRT) is a treatment for heart failure patients. The global market for CRT is witnessing significant growth due to the rising prevalence of cardiovascular diseases worldwide. CRT devices help restore synchronized heart contractions, improving cardiac function and quality of life. Factors such as technological advancements, increasing awareness, and the growing geriatric population are driving market expansion. Moreover, favorable reimbursement policies and ongoing research and development activities are expected to further fuel the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Cardiac Resynchronization Therapy and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Global Cardiac Resynchronization Therapy Market is segmented based on the Type, Application, End User and region. Based on Type Global market is segmented into CRT-Defibrillator and CRT-Pacemaker. Based on the Application into Intraventricular desynchrony, Interventricular (V-V) desynchrony, Atrioventricular (A-V) desynchrony. Based on the End User into Hospitals, Cardiac Care Centres, and Ambulatory Surgical Centres. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Despite advancements in prevention and therapy, approximately 50% of deaths caused by cardiovascular diseases are due to sudden cardiac death. This remains a significant cause of mortality. The prevalence of heart diseases and their risk factors is increasing, leading to a higher demand for cardiac resynchronization therapy devices. Heart failure is one of the primary contributors to global mortality.

Restrain

In June 2022, Boston Scientific Corporation initiated a recall for the INGENIO family of pacemakers and CRT-Ps. Some of the affected devices include ADVANTIO DR EL, INGENIO DR EL, and VITALIO DR EL. These devices were distributed between November 2016 and August 2022, after being manufactured from September 2016 to December 2018. Approximately 48,000 devices were recalled in the United States due to the potential safety mode activation.

Trend

Patients with heart failure who are at a high risk of sudden cardiac death should consider using CRT-Defibrillators (CRT-D). A CRT-D device treats slow heart rhythms like a regular pacemaker, but it also delivers small electrical impulses to the left and right ventricles to facilitate synchronized contractions. This improves the efficiency of heart pumping. Furthermore, CRT-D devices can address arrhythmias, which are rapid and dangerous heartbeats that may lead to sudden cardiac arrest. If the device detects such rapid heartbeats, it delivers a shock to the heart, known as defibrillation, to restore a regular rhythm. Without this life-saving treatment, the rapid pulse can result in death within minutes. These devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications. They are favored by patients due to their user-friendly design, longer battery life, and compatibility with MRI scans. Given the increasing incidence and mortality of cardiovascular diseases, the demand for these devices has recently risen.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Cardiac Resynchronization Therapy Market by Type

  • Market Overview
  • CRT-Defibrillator and CRT-Pacemaker

Global Cardiac Resynchronization Therapy Market by Application

  • Market Overview
  • Intraventricular desynchrony
  • Interventricular (V-V) desynchrony
  • Atrioventricular (A-V) desynchrony

Global Cardiac Resynchronization Therapy Market by End User

  • Market Overview
  • Hospitals
  • Cardiac Care Centres
  • and Ambulatory Surgical Centres

Global Cardiac Resynchronization Therapy Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBR Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Dimensions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osprey Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioVentrix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InspireMD, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syncardia Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiva Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments